NCI and Rockland Have Added New Antibodies to Thriving Collaboration Portfolio

Date Posted:







The National Cancer Institute (NCI) has partnered with Rockland Immunochemicals to develop, in conjunction with the NCI’s Center for Cancer Research (CCR), nearly 100 antibodies involved in signal transduction and cancer research.


View the Full Newsletter Here.